Rankings
▼
Calendar
ONC Q4 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q4 2021 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$214M
+113.8% YoY
Gross Profit
$165M
77.3% margin
Operating Income
-$572M
-267.2% margin
Net Income
-$586M
-273.7% margin
EPS (Diluted)
$-6.11
QoQ Revenue Growth
+3.7%
Cash Flow
Operating Cash Flow
-$508M
Free Cash Flow
-$666M
Stock-Based Comp.
$63M
Balance Sheet
Total Assets
$8.5B
Total Liabilities
$2.4B
Stockholders' Equity
$6.1B
Cash & Equivalents
$4.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$214M
$100M
+113.8%
Gross Profit
$165M
$79M
+109.4%
Operating Income
-$572M
-$485M
-17.9%
Net Income
-$586M
-$473M
-23.9%
← FY 2021
All Quarters
Q1 2022 →